Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hormone replacement therapy in cancer survivors: Utopia?
Angioli R, Luvero D, Armento G, Capriglione S, Plotti F, Scaletta G, Lopez S, Montera R, Gatti A, Serra GB, Benedetti Panici P, Terranova C. Angioli R, et al. Among authors: armento g. Crit Rev Oncol Hematol. 2018 Apr;124:51-60. doi: 10.1016/j.critrevonc.2018.02.005. Epub 2018 Feb 8. Crit Rev Oncol Hematol. 2018. PMID: 29548486 Review.
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials.
Santoni M, Conti A, Andrikou K, Bittoni A, Lanese A, Pistelli M, Pantano F, Vincenzi B, Armento G, Massari F, Tonini G, Cascinu S, Santini D. Santoni M, et al. Among authors: armento g. Crit Rev Oncol Hematol. 2015 Nov;96(2):206-19. doi: 10.1016/j.critrevonc.2015.05.007. Epub 2015 Jun 10. Crit Rev Oncol Hematol. 2015. PMID: 26070625 Review.
Developing drugs in cancer-related bone pain.
Lucchesi M, Lanzetta G, Antonuzzo A, Rozzi A, Sardi I, Favre C, Ripamonti CI, Santini D, Armento G. Lucchesi M, et al. Among authors: armento g. Crit Rev Oncol Hematol. 2017 Nov;119:66-74. doi: 10.1016/j.critrevonc.2017.08.005. Epub 2017 Aug 25. Crit Rev Oncol Hematol. 2017. PMID: 28893462 Review.
Drug-induced hepatotoxicity in cancer patients - implication for treatment.
Vincenzi B, Armento G, Spalato Ceruso M, Catania G, Leakos M, Santini D, Minotti G, Tonini G. Vincenzi B, et al. Among authors: armento g. Expert Opin Drug Saf. 2016 Sep;15(9):1219-38. doi: 10.1080/14740338.2016.1194824. Epub 2016 Jun 14. Expert Opin Drug Saf. 2016. PMID: 27232067 Review.
Denosumab for cancer-related bone loss.
Dell'Aquila E, Armento G, Iuliani M, Simonetti S, D'Onofrio L, Zeppola T, Madaudo C, Russano M, Citarella F, Ribelli G, Pantano F, Vincenzi B, Tonini G, Santini D. Dell'Aquila E, et al. Among authors: armento g. Expert Opin Biol Ther. 2020 Nov;20(11):1261-1274. doi: 10.1080/14712598.2020.1814731. Epub 2020 Sep 9. Expert Opin Biol Ther. 2020. PMID: 32835531 Review.
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.
Santini D, Schiavon G, Vincenzi B, Gaeta L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, La Verde N, Caroti C, Treilleux I, Ruggiero A, Perrone G, Addeo R, Clezardin P, Muda AO, Tonini G. Santini D, et al. Among authors: armento g. PLoS One. 2011 Apr 29;6(4):e19234. doi: 10.1371/journal.pone.0019234. PLoS One. 2011. PMID: 21559440 Free PMC article.
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.
Rinaldi S, Santoni M, Leoni G, Fiordoliva I, Marcantognini G, Meletani T, Armento G, Santini D, Newsom-Davis T, Tiberi M, Morgese F, Torniai M, Bower M, Berardi R. Rinaldi S, et al. Among authors: armento g. Support Care Cancer. 2019 Apr;27(4):1255-1261. doi: 10.1007/s00520-018-4489-2. Epub 2018 Nov 8. Support Care Cancer. 2019. PMID: 30406916
25 results